Clinical TrialsSearch results
Number of results: 416
Other
- A multi institutional phase II study of oral fludarabine and rituximab (F-R therapy) for patients with relapsed or refractory mantle cell lymphoma.
- Mantle cell lymphoma
- Hematological Malignancy Clinical Study Group
- 2008-10-11
Other
- A phase2 study of Rituximab+THP-COP(R-THP-COP) in elderly subjects with untreated, advanced, CD20-positive, indolent B-cell Non-Hodgkin's lymphoma
- indolent B-cell lymphoma
- Hematological Malignancy Clinical Study Group
- 2009-08-03
Other
- Phase I trial neoadjuvant chemoradiation therapy with gemcitabine and surgical resection for cholangiocarcinoma
- cholangiocarcinoma
- Hepato-biliary pancreatic surgery, Tohoku University Hospital
- 2008-01-24
Other
- Phase II trial neoadjuvant chemoradiation therapy with gemcitabine and surgical resection for advanced cholangiocarcinoma patients
- cholangiocarecinoma:Stage III and IV of the Japanese General Rules for Surgical and Pathological Studies on Cancer of the Biliary Tract
- Hepato-biliary pancreatic surgery,Tohoku University Hospital
- 2009-03-04
Other
- A Phase III, Randomized, Multicenter, Double-blind, Placebo-controlled Study of Durvalumab for the Treatment of Stage II-III NSCLC Patients With Minimal Residual Disease Following Surgery and Curative Intent Therapy.
- Carcinoma, Non- Small Cell Lung
- Hibi Kazushige
- 2020-12-16
Other
- The Heart Institute of Japan Candesartan Randomized trial for Evaluation in Coronary Artery Disease
- Coronary artery disease
- HIJC Study group
- 2007-11-07
Other
- Randomized , double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of belimumab for early systemic lupus erythematosus
- Systemic Lupus Erythematosus : SLE
- Hiroko Sato
- 2021-10-14
Other
- Phase II study of amrubicin for non-small lung cancer after failure of two or three prior chemotherapy regimens
- NSCLC after failure of two or three prior chemotherapy regimes
- Hokkaido Lung Cancer Clinical Study Group
- 2009-08-07
Other
- Hypertension Objective Treatment Based on Measurement by Electrical Devices of Blood Pressure (HOMED-BP) Study: Prospective Randomized Open-label Blinded Endpoint (PROBE)
- Untreated essential hypertensive patients
- HOMED-BP Study Group
- 2005-09-09
Other
- Health Promotion Program for Piabetes prevention (HPDP)
- diabetes
- HPDP research group
- 2005-10-01